![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/08/01/2922614/0/en/C4-Therapeutics-Reports-Second-Quarter-2024-Financial-Results-and-Recent-Business-Highlights.html
https://www.globenewswire.com/news-release/2024/07/16/2914143/0/en/C4-Therapeutics-to-Present-Preliminary-Monotherapy-Data-from-the-Ongoing-Phase-1-Trial-of-CFT1946-as-a-Mini-Oral-Presentation-at-the-ESMO-Congress-2024.html
https://www.globenewswire.com/news-release/2024/07/08/2909482/0/en/C4-Therapeutics-to-Participate-in-the-Virtual-UBS-Targeted-Protein-Degradation-Day.html
https://www.globenewswire.com/news-release/2024/06/10/2895874/0/en/C4-Therapeutics-Appoints-Ron-Cooper-as-Chairman-of-the-Board-of-Directors.html
https://www.globenewswire.com/news-release/2024/05/08/2877681/0/en/C4-Therapeutics-Reports-First-Quarter-2024-Financial-Results-and-Recent-Business-Highlights.html
https://www.globenewswire.com/news-release/2024/04/29/2871619/0/en/C4-Therapeutics-Announces-Inducement-Grant-Under-Nasdaq-Listing-Rule-5635-c-4.html
https://www.globenewswire.com/news-release/2024/04/09/2859837/0/en/C4-Therapeutics-to-Participate-in-the-Stifel-2024-Targeted-Oncology-Forum.html
https://www.globenewswire.com/news-release/2024/04/08/2859100/0/en/C4-Therapeutics-Presents-New-Preclinical-Data-for-CFT1946-Highlighting-Superior-Activity-as-a-Single-Agent-to-Clinically-Approved-BRAF-Inhibitor-Standard-of-Care-Combinations-at-th.html
https://www.fiercebiotech.com/biotech/c4-sparks-new-collab-merck-kgaa-looks-right-ship-after-earlier-layoffs
https://www.globenewswire.com//news-release/2024/03/05/2840942/0/en/C4-Therapeutics-to-Present-New-Preclinical-Data-on-Highly-Selective-Orally-Bioavailable-BiDAC-Degraders-at-the-American-Association-for-Cancer-Research-Annual-Meeting-2024.html